This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

DepoMed Inc (DEPO)

NASDAQ: Health Care

Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 390.36M 134.21M 90.82M 132.97M
Cost of Sales 8.79M 4.70M 5.17M 5.12M
Gross Operating Profit 381.57M 129.51M 85.65M 127.85M
Selling, General, and Administrative Expenses 121.13M 105.18M 97.65M 54.20M
Research & Development 7.12M 8.07M 15.46M 15.19M
Operating Income before D & A (EBITDA) 253.33M 16.26M -27.46M 31.12M
Depreciation & Amortization 16.51M 6.94M 2.89M 420.00K
Interest Income 215.00K 662.00K 520.00K 557.00K
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 40.00M
Total Income Before Interest Expenses (EBIT) 237.03M 9.98M -29.83M 71.25M
Interest Expense 23.92M 5.40M 39.00K 133.00K
Pre-Tax Income 213.11M 4.58M -29.87M 71.12M
Income Taxes 81.35M -38.73M -91.00K 396.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 131.76M 43.31M -29.78M 70.73M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 131.76M 43.31M -29.78M 70.73M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 131.76M 43.31M -29.78M 70.73M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
131.76M 43.31M -29.78M 30.73M
Preferred Dividends
Net Income Available To Common 131.76M 43.31M -29.78M 70.73M
Basic EPS from Continuing Ops. 2.26 0.76 -0.53 1.30
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.26 0.76 -0.53 1.30
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.26 0.76 -0.53 1.30
Basic Normalized Net Income/Share 2.26 0.76 -0.53 0.56
EPS fr Continuing Ops. 1.99 0.75 -0.53 1.26
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.99 0.75 -0.53 1.26
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.06 0.00 0.00 0.00
EPS, Total 2.05 0.75 -0.53 1.26
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.99 0.75 -0.53 0.55
Dividends Paid per Share 0.00 0.00 0.00 0.00
DEPO News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for DEPO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 3 2 2 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET DEPO ANALYST REPORT

DEPO Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs